SCHEMBL8105060

SCHEMBL8105060

O=C(Cl)C1(c2ccc3ccccc3c2)CCC1

nearest known ligand 0.50

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.50
OPRM1 P35372 1/20 0.45
SLC6A3 Q01959 9/20 0.44
SLC6A4 P31645 8/20 0.44
SLC6A2 P23975 5/20 0.44
HDAC3 O15379 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
AKR1C1 Q04828 1/20 0.41
KCNH2 Q12809 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8110644 0.85 AKR1C1 (0.59) HDAC1OPRM1SLC6A3SLC6A4SLC6A2
SCHEMBL7366815 0.83 HDAC1 (0.50) HDAC1OPRM1SLC6A3SLC6A4SLC6A2
SCHEMBL3520383 0.80 AKR1C1 (0.62) HDAC1SLC6A3SLC6A4SLC6A2AKR1C1
SCHEMBL27511149 0.80 OPRM1 (0.51) HDAC1OPRM1SLC6A3SLC6A4SLC6A2
SCHEMBL7371503 0.80 HDAC1 (0.47) HDAC1OPRM1SLC6A3SLC6A4SLC6A2
SCHEMBL248544 0.78 AKR1C1 (0.64) HDAC1AKR1C1
SCHEMBL349729 0.77 AKR1C1 (0.53) HDAC1OPRM1SLC6A3SLC6A4HDAC3
SCHEMBL8848428 0.75 ALDH1A1 (0.41) SLC6A4SLC6A2
SCHEMBL6349290 0.74 AKR1C1 (0.70) HDAC1AKR1C1
SCHEMBL5138906 0.73 AKR1C3 (0.33) HDAC1OPRM1HDAC3HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6124354-A TREATMENT OF URINARY INCONTINENCE OR IRRITABLE BOWEL SYNDROME PHARMACIA & UPJOHN AB (SE) 2000-09-26 US disclosed
EP-0923536-A1 ARYLCYCLOALKANE CARBOXYLIC ESTERS, THEIR USE, PHARMACEUTICAL COMPOSITIONS AND PREPARATION Pharmacia & Upjohn Aktiebolag (SE) 1999-06-23 EP disclosed
WO-1998004517-A1 ARYLCYCLOALKANE CARBOXYLIC ESTERS, THEIR USE, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PHARMACIA & UPJOHN AB (SE) 1998-02-05 WO disclosed